Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.

Evans, Elizabeth E

Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies. [electronic resource] - Cancer immunology research Jun 2015 - 689-701 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2326-6074

10.1158/2326-6066.CIR-14-0171 doi


Animals
Antibodies, Blocking--administration & dosage
Antibodies, Monoclonal--administration & dosage
Antigen-Presenting Cells--immunology
Antigens, CD--immunology
Antineoplastic Agents--pharmacology
Breast Neoplasms--immunology
CTLA-4 Antigen--antagonists & inhibitors
Cell Line, Tumor
Cyclophosphamide--pharmacology
Cytokines--metabolism
Disease Models, Animal
Drug Synergism
Female
Humans
Immunologic Memory
Immunomodulation--drug effects
Immunotherapy
Lymphocyte Subsets--drug effects
Lymphocytes, Tumor-Infiltrating--drug effects
Mice
Neoplasms--immunology
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Receptor, ErbB-2--metabolism
Semaphorins--antagonists & inhibitors
Tumor Burden--immunology
Tumor Microenvironment--drug effects
Xenograft Model Antitumor Assays